News

Filter

Current filters:

None

37 to 46 of 96312 results

ESMO 2014: GSK reports 45% survival rate in Tafinlar trial

ESMO 2014: GSK reports 45% survival rate in Tafinlar trial

29-09-2014

UK pharma major GlaxoSmithKline presented data at the European Society for Medical Oncology’s congress…

DacarbazineGlaxoSmithKlineOncologyPharmaceuticalResearchTafinlarUK

Perrigo sells some preclinical assets to Imago

Perrigo sells some preclinical assets to Imago

29-09-2014

US heath care firm Perrigo says it has transferred a portfolio of preclinical research assets, which…

Imago PharmaceuticalsMergers & AcquisitionsNeurologicalPerrigoPharmaceuticalUSA

EXPERT VIEW: Utilizing supplementary protection certificates for active ingredients in the pharma industry

EXPERT VIEW: Utilizing supplementary protection certificates for active ingredients in the pharma industry

29-09-2014

Intellectual Property can be vital for the success of any pharmaceutical invention. It is very important…

EuropeInterviewsLegalPatentsPharmaceuticalUnited Kingdom

ESMO 2014: Canada and Europe sometimes years slower than USA in approving cancer

ESMO 2014: Canada and Europe sometimes years slower than USA in approving cancer

29-09-2014

Access to potentially life-extending cancer drugs varies significantly in different regions of the world,…

CanadaEastern EuropeEuropeOncologyPharmaceuticalRegulationUSA

Daiichi Sankyo to buy Ambit Biosciences for up to $410 million

Daiichi Sankyo to buy Ambit Biosciences for up to $410 million

29-09-2014

Daiichi Sankyo and Ambit Biosciences have entered into a definitive merger agreement under which Daiichi…

Ambit BiosciencesBiotechnologyDaiichi SankyoJapanMergers & AcquisitionsOncologyquizartinib

Horizon Discovery acquires Sage Labs for $48 million

Horizon Discovery acquires Sage Labs for $48 million

29-09-2014

UK-based Horizon Discovery Group has agreed to acquire Sage Labs of the USA for up to $16 million in…

GeneticsHorizon DiscoveryMergers & AcquisitionsPharmaceuticalSage LabsUKUSA

Sigmoid in licensing deal with Pendopharm for CyCol in Canada

Sigmoid in licensing deal with Pendopharm for CyCol in Canada

29-09-2014

Irish drug delivery technology company Sigmoid Pharma has entered into agreements with Canada’s Pendopharm,…

CanadaCyColFinancialGastro-intestinalsLicensingPendopharmPharmaceuticalPharmascienceSigmoid Pharma

37 to 46 of 96312 results

Back to top